Adult-onset type 1 diabetes is associated with an increased risk for death and major adverse cardiovascular events.

Researchers have found that, among nulliparous patients, hypertensive disorders of pregnancy significantly increase risk for incident atrial fibrillation.

Shorter breastfeeding duration and younger age at first birth are known risk factors for triple negative breast cancer and vary by race.

Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, T2D and other metabolic diseases.

Topline data were announced from a phase 3 trial evaluating olezarsen in patients with moderate hypertriglyceridemia with or at risk for ASCVD.